Antimicrobial Therapy in Immunocompromised and Critically Ill Patients: Management and Perspectives

WELCOME TO LUGANO

Immunocompromised and intensive care (ICU) patients are exposed to viral, bacterial and fungal infections that complicate the already difficult therapy of the underlying diseases. The emergence of resistant viral, bacterial and fungal strains as well as the report of new opportunistic pathogens makes treatment of these patients a daunting task. New antivirals have actually expanded the therapeutic options in the treatment of viral infections, particularly HCV and HIV. New diagnostic tools as well as old and new antibacterial and antifungal agents are available to support the fight against infectious diseases in ICU, oncological and transplant patients, but viral, bacterial and fungal diseases still cause unacceptably high mortality rates in all these patients.

This congress aims at providing first-hand and up-to-date information on the management of infectious diseases and the most appropriate antimicrobial therapy in immunocompromised and critically ill patients. 
 
International experts will highlight the latest progress in research on various aspects of infectious diseases and their therapy during plenary sessions and the interactive case session. Special attention will be devoted to infectious complications in oncologic and transplant patients. Further highlights will be some controversial issues in the management of ICU patients with infections, as well as the most recent treatment approaches for HIV and HCV.
Integrated industry-sponsored symposia will provide the most recent data on the treatment of specific viral and bacterial infections.

The Palazzo dei Congressi, conveniently located at walking distance from the Main Station and downtown, is the ideal venue to host this highly educational meeting. We are looking forward to seeing you in Lugano for what we are sure will be not only a very interesting but also a pleasant stay – and please make sure to enjoy not only the congress but also the beautiful surroundings. 

OBJECTIVES

This congress will discuss the most common issues and controversies related to infectious diseases in these groups of patients, with the aim of providing not only theoretical but also real-life experience to be then easily translated into daily clinical practice.

WHO SHOULD ATTEND

Infectious disease and intensive care specialists, haemato-oncologists and oncologists, transplant specialists, clinical microbiologists, as well as to other health professionals involved in the care of critically ill and immunocompromised patients.

CONGRESS PRESIDENT

Luigia Elzi, MD

Locarno, Switzerland

scientific committee

Enos Bernasconi, MD

Lugano, Switzerland

Christian Garzoni, MD

Lugano, Switzerland

Paolo Grossi, MD

Varese, Italy

Oscar Marchetti, MD

Nyon, Switzerland

Orlando Petrini, PhD

Lugano, Switzerland